Abstracts tagged "SLE and quality of life"

Abstract Number: 648 • 2019 ACR/ARP Annual Meeting
Patients of African Descent Score Higher on Quality of Life Indices Despite Their Known Disease Severity
Katie Zuech¹, Ly Tran ², Teresa Aberle ¹, Cristina Arriens ³, Eliza F. Chakravarty ³, Joan T. Merrill ⁴ and Judith James ³, ¹Oklahoma Medical Research Foundation, Oklahoma City, OK, ²Oklahoma Medical Research Foundation, Oklahoma City, ³Oklahoma Medical Research Foundation, University of Oklahoma Health Sciences Center, Oklahoma City, OK, ⁴Okalahoma Medical Research Foundation, Oklahoma City, OK
Background/Purpose: Systemic lupus (SLE) may have a significant impact on multiple dimensions of quality of life. Patient-reported outcome (PRO) tools may provide valuable insights for…
Abstract Number: 1682 • 2018 ACR/ARHP Annual Meeting
Correlation between SLE Specific and Generic Health Related Quality of Life Surveys, and Their Association with Patient Global Rating of Change and Lupus Low Disease Activity State: A Longitudinal Study
Worawit Louthrenoo¹, Nuntana Kasitanon¹, Eric Morand² and Rangi Kandane-Rathnayake³, ¹Division of Rheumatology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand, ²Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia, ³School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia
Background/Purpose: To determine the correlation between SLE-specific and generic patient reported outcomes measures (PROs), and to examine their associations with patients’ global rating of change…
Abstract Number: 2630 • 2014 ACR/ARHP Annual Meeting
An Evaluation of Quality of Life of Patients with Systemic Lupus Erythematosus Attending Rheumatology Clinic in Kenyatta National Hospital, Nairobi, Kenya
Jackline Odhiambo, internal medicine, university of nairobi, nairobi, Kenya
Background/Purpose Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease that affects all organs of the body. Due to its chronicity SLE has been known…
Abstract Number: 717 • 2014 ACR/ARHP Annual Meeting
Comparison of Responsiveness of Lupus Impact Tracker with Lupus Quality of Life to Selena Responder Index
Hervé Devilliers¹, Narender Annapureddy², Winston Sequeira³, Joel A Block⁴ and Meenakshi Jolly², ¹Dijon University Hospital, Department of internal medicine and systemic diseases, Dijon, France, ²Rheumatology, Rush University Medical Center, Chicago, IL, ³rush university, chicago, IL, ⁴Rush University, Chicago, IL
Background/Purpose: Lupus Impact Tracker (LIT) is a 10-item patient reported outcome tool to measure the impact of Systemic Lupus Erythematosus (SLE) or its treatment on…
Abstract Number: 188 • 2013 ACR/ARHP Annual Meeting
Can MDHAQ/RAPID3 Be Used In Usual Care Of Patients With Systemic Lupus Erythematosus?
Narender Annapureddy¹, Theodore Pincus¹, Joel A. Block² and Meenakshi Jolly¹, ¹Rheumatology, Rush University Medical Center, Chicago, IL, ²Section of Rheumatology, Rush University Medical Center, Chicago, IL
Background/Purpose: Disease-specific patient reported outcome (PRO) tools are uniquely informative for the management of systemic lupus erythematosus (SLE) patients. However, it is difficult to incorporate…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].